Results 1 to 10 of about 153,949 (242)

Seroprevalence of hepatitis B and hepatitis C viral infections among refugees in Muzaffarabad, Pakistan [PDF]

BMC Infectious Diseases
Background Hepatitis B (HB) and Hepatitis C (HC) viral infections, with 328 million cases globally, represent a significant disease burden. Currently, Pakistan has 3.88 million HB and 9.31 million HC cases.
Yasir Waheed, Sohail Naser Awan, Fahad Nasser Almajhdi, Bashir Ahmad, Abdul Sami, Dilber Uzun Ozsahin   +5 more
doaj   +2 more sources

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021

BMJ Global Health, 2022
Introduction Estimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies.
, Anthony Nardone, Jesse Papenburg, Marta Valenciano, Hude Quan, Maria D Van Kerkhove, Didier K Ekouevi, Tyler Williamson, Shobna Sawry, Xiaomeng Ma, Ambrose Talisuna, Thierno Balde, Ines Vigan-Womas, David Buckeridge, Halidou Tinto, Michael Liu, Tingting Yan, Matthew P Cheng, Joseph Okeibunor, Samiratou Ouedraogo, Francine Ntoumi, Cheikh Talla, David Clifton, Tiffany G Harris, Ayôla A Adegnika, Lorenzo Subissi, Laura Steinhardt, Niklas Bobrovitz, Isidore T Traore, Timothy G Evans, Judy Chen, Cedric P Yansouni, Cheryl Cohen, Jason M Mwenda, Nsenga Ngoy, Hannah C Lewis, Harriet Ware, Mairead Whelan, Zihan Li, Brianna Cheng, Kim Noel, Christian Cao, Mercedes Yanes-Lane, Belinda L Herring, Rahul K Arora, Isabel Bergeri, Rafiou Adamou, Samira Z Assoumou, Rosemary A Audu, Jacob S Barnor, Enyew Birru, Henry K Bosa, Emily L Boucher, Annie Chauma-Mwale, Tienhan S Dabakuyo-Yonli, Gabriel Deveaux, Boly Diop, Titus H Divala, Emily K Dokubo, Irene O Donkor, Claire Donnici, Nathan Duarte, Natalie A Duarte, Paulin N Essone, Lee Fairlie, Ousmane Faye, Anne von Gottberg, Natasha Ilincic, Elsie A Ilori, Jackie Kleynhans, Dayoung Kim, Olatunji M Kolawole, Jambo C Kondwani, Emma Loeschnik, Sheila Makiala-Mandanda, Alexandre Manirakiza, Pinyi N Mawien, Portia C Mutevedzi, Edgard B Ngoungou, Eric M Osoro, Sandrine L Oyegue, Sara Perlman-Arrow, Hannah P Rahim, Karampreet Sachathep, Mitchell Segal, Anabel Selemon, Judith Shang, Joel F Djoba Siawaya, Kristen A Stafford, Joe A Theu, Caseng Zhang   +90 more
doaj   +1 more source

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

Emerging Infectious Diseases, 2023
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%).
Rebecca A. Falender, Paul G. Mitchell, Judith A. Guzman-Cottrill, Paul R. Cieslak, Melissa Sutton   +4 more
doaj   +1 more source

Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia

International Journal of Infectious Diseases, 2021
Background: Serologic testing provides better understanding of SARS-CoV-2 prevalence and its transmission. This study was an investigation of the prevalence of antibodies to SARS-CoV-2 among blood donors in Saudi Arabia.
Ayman Banjar, Jaffar A. Al-Tawfiq, Amaal Alruwaily, Haleema Alserehi, Ada Al-Qunaibet, Rehab Alaswad, Hind Almutlaq, Abdullah Almudaiheem, Abdullah T. Khojah, Faisal Alsaif, Shaza Karim Almolad, Saeed Alqahtani, Abdullah AlJurayyan, Abdullah Alotaibi, Safar Almalki, Yousef Abuhaimed, Abdullah Alkhashan, Amal Alfaifi, Khaled Alabdulkareem, Hani Jokhdar, Abdullah Assiri, Sami Almudarra   +21 more
doaj   +1 more source

Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population. [PDF]

PLoS ONE, 2016
We investigated Estonian population and its selected subgroups for serological evidence of exposure to Ascaris lumbricoides, Echinococcus spp., Taenia solium, Toxocara canis, Toxoplasma gondii, and Trichinella spiralis.
Brian Lassen, Marilin Janson, Arvo Viltrop, Kädi Neare, Pirje Hütt, Irina Golovljova, Lea Tummeleht, Pikka Jokelainen   +7 more
doaj   +1 more source

Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children

Swiss Medical Weekly, 2023
BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist.
Sarah R. Haile, Alessia Raineri, Sonja Rueegg, Thomas Radtke, Agne Ulyte, Milo A. Puhan, Susi Kriemler   +6 more
doaj   +1 more source

Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria

Parasite Epidemiology and Control, 2021
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals.
Falmata Kyari, PhD, Albert Wulari Mbaya, PhD, Abdullahi Abubakar Biu, PhD, Lawan Adamu, PhD, Okoro Ogbonna Dennis, MVSc   +4 more
doaj   +1 more source

Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown

BMC Infectious Diseases, 2022
Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively.
Yueting Tang, Jiayu Sun, Yumeng Yuan, Fen Yao, Bokun Zheng, Gui Yang, Wen Xie, Guangming Ye, Zhen Li, Xiaoyang Jiao, Yirong Li   +10 more
doaj   +1 more source

Spanish HCMV Seroprevalence in the 21st Century

Viruses, 2023
Human cytomegalovirus (HCMV) is linked to age-related diseases like cardiovascular disease, neurodegenerative conditions, and cancer. It can also cause congenital defects and severe illness in immunocompromised individuals.
Pablo Álvarez-Heredia, Irene Reina-Alfonso, José Joaquín Domínguez-del-Castillo, Fakhri Hassouneh, Carmen Gutiérrez-González, Alexander Batista-Duharte, Ana-Belén Pérez, Fernando Sarramea, María José Jaén-Moreno, Cristina Camacho-Rodríguez, Raquel Tarazona, Rafael Solana, Juan Molina, Alejandra Pera   +13 more
doaj   +1 more source

SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland

Swiss Medical Weekly, 2022
BACKGROUND: Few studies have directly examined the incidence or seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in children, parents and teachers from the same school communities.
Agne Ulyte, Sarah R. Haile, Jacob Blankenberger, Thomas Radtke, Milo A. Puhan, Susi Kriemler   +5 more
doaj   +1 more source